- €41.85m
- €100.77m
- €5.79m
- 33
- 39
- 58
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.26 | 3.29 | 81.1 | 4.85 | 5.79 |
Cost of Revenue | |||||
Gross Profit | 3.18 | 2.74 | 16 | 3.96 | 4.68 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.95 | 1.71 | 60.3 | 4.79 | 8.49 |
Operating Profit | -0.692 | 1.58 | 20.8 | 0.054 | -2.71 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.94 | -1.11 | 28.5 | 2.25 | -6.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.37 | -1.25 | 26.8 | 1.51 | -6.42 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.73 | -1.64 | 25 | 3.33 | -6.42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.73 | -1.64 | 25 | 3.33 | -6.42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.388 | -0.121 | 2.38 | 0.134 | -0.57 |
Dividends per Share |